Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health | FMCG | Executive
         
Latest Jobs
Exclusive vacancies may not be shown here, please contact Mark on +44 1494 818 049 or markd@zenopa.com for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Mark Denton
Managing Director
markd@zenopa.com
+44 1494 818 049

Testimonials
Zenopa worked very hard and provided me with great results when I needed to hire several Business Development Managers, I would definitely recommend and will be using again.
Chris, 2012

Ansell launches new Gammex Powder-Free gloves in Europe

5 December 2011 00:00 in Medical Company Product News


Ansell has announced the launch of its new Gammex Powder-Free gloves with AMT Antimicrobial Technology in Europe.

The new surgical glove offering has been available in Australia since 2010 and is now being introduced internationally, providing safety and comfort benefits for users.

Gammex is the first surgical glove to incorporate a proprietary antimicrobial coating, offering a clinically-proven second level of protection to users in case the glove itself is breached in any way.

Their natural rubber latex composition also provides enhanced sensitivity and low allergenicity, with Ansell to demonstrate the product to European users at medical conferences over the coming months.

Marcus Heimann, marketing director for medical solutions in the EMEA and India region at Ansell Healthcare, said: "Gammex Powder-Free with AMT acts like a second skin, with its own immune system to further protect surgical teams against harmful pathogens."

This comes after the firm announced last month that it has purchased a minority stake in Yulex Corporation, a manufacturer of guayule-derived biopolymers for use in creating gloves that can minimise allergic reactions.ADNFCR-8000103-ID-801229860-ADNFCR

Other news stories from 05/12/2011

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Adfero News Agency



             
© Copyright 2013 Zenopa Ltd